Healthcare Professionals

  • Email
  • Help

Information for you

On this page, you will find information on the Agency’s activities that are most relevant to healthcare professionals, including news, and events.

You can contribute to the Agency’s work by responding to public consultations

Learn more about how Healthcare Professionals are actively involved in the work of the Agency.

Featured information

  • Antibiotic awareness initiatives, 13-19 November 2017

    EMA has published a package of information in support of World Antibiotic Awareness Week from 13 to 19 November and European Antibiotic Awareness Day on 18 November. This includes a visual guide to how the EU agencies support the fight against antibiotic resistance and a meeting report and video on its joint info session with the European Centre for Disease Prevention and Control on antimicrobial resistance in September, involving EMA's working parties for patients and consumers and for healthcare professionals. For more information, see Antimicrobial resistance.

  • Ten-year report on implementation of the Paediatric Regulation

    In October 2017, the European Commission published a report on progress made in children's medicines since the Paediatric Regulation came into force 10 years ago. The report shows an increase in medicines for children in many therapeutic areas in the last ten years, most notably in rheumatology and infectious diseases. However, it also shows that little progress has been made in diseases that only affect children or where the disease shows biological differences between adults and children, particularly rare diseases. The Commission and EMA and its Paediatric Committee will develop an action plan to improve the implementation of the Regulation.

  • public_hearing_report

    Public hearing at EMA

    Patients, carers, doctors, pharmacists and academics shared their experiences with valproate, a medicine currently prescribed for epilepsy, bipolar disorder and migraine, at EMA’s public hearing on 26 September 2017. 65 people attended including 28 patients and patient representatives, 19 healthcare professionals and academics, 11 attendees from pharmaceutical industry and 7 from media. There were 25 speaker contributions,grouped into 16 speaker slots. The European Parliament representative concluded that the hearing was a positive experience. A summary report is available.

  • Joint meeting of patients and consumers and healthcare professionals working parties

    EMA held a joint meeting of the Patients' and Consumers' Working Party (PCWP) and the Healthcare Professionals' Working Party (HCPWP) on 20 September. Topics included work plans for 2018-19, proposed revision of their mandates and rules of procedure, streamlining the eligibility status re-assessment processes, compassionate use of medicines, EMA preparedness for Brexit, EMA’s first public hearing and next steps following the European Commission report on product information. All presentations are available.

  • biosimilars

    Biosimilar medicines

    EMA and the European Commission have published an information guide for healthcare professionals on the science and regulation underpinning the use of biosimilar medicines. EU scientific experts and organisations representing doctors, nurses, pharmacists and patients contributed to the development of this guide.

News for healthcare professionals

Events of interest

Information for:

Find information for...

FAQ spotlight